Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Clinical and endocrinological findings in ectopic pinealoma and spongioblastoma of the hypothalamus
1980
Astrocytomas of the cerebellum: A comparative clinicopathologic study of pilocytic and diffuse astrocytomas
1993
Acromegaly
2006 Standout
Dopamine Resistance of Prolactinomas
2003
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Cushing's syndrome
2015 Standout
Malignant gliomas of the cerebellum: An analytic review
1998
MEDICAL TREATMENT OF PROLACTINOMAS
1999
The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma
1992
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Prolactinoma
2003
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
2009
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Epidermal Growth Factor Induces the Functional Expression of Dopamine Receptors in the GH3 Cell Line*
1991
Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases
1997 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Successful Treatment of Recurrent Malignant Germ Cell Tumors
1993
Posterior fossa medulloblastoma in childhood: Treatment results and a proposal for a new staging system
1990
Medical therapy for clinically non-functioning pituitary adenomas
2008
Primary cerebellar glioblastoma multiforme
1987
Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women
2006
Adult Cerebellar Glioblastoma: Understanding Survival and Prognostic Factors Using a Population-Based Database from 1973 to 2009
2013
Tumorigenesis and the angiogenic switch
2003 Standout
Pituitary Tumor Registry: A Novel Clinical Resource1
2000
Intracranial germ-cell tumors: natural history and pathogenesis
1985 Standout
Beneficial Effects of High Daily Dose Bromocriptine Treatment in Cushing's Disease.
1992
Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment
1985
Mutism and Pseudobulbar Symptoms after Resection of Posterior Fossa Tumors in Children
1995 Standout
Rapid Regression of Pituitary Prolactinomas during Bromocriptine Treatment*
1980
Advances in the Treatment of Prolactinomas
2006
Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide
2000
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
The Significance of Atypia and Histologic Malignancy in Pilocytic Astrocytoma of the Cerebellum: A Clinicopathologic and Flow Cytometric Study
1994
Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide
2000
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
1993
Primary intracranial germ cell tumours
1973
Works of G. Luccarelli being referenced
Ectopic pinealomas of the optic nerves and chiasma
1972
Glioblastoma multiforme of the cerebellum: Description of three cases
1980
Cushing’s disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment
1984
SIZE REDUCTION OF A PROLACTIN SECRETING ADENOMA DURING LONG‐TERM TREATMENT WITH THE DOPAMINE AGONIST LISURIDE
1980
Effect of chronic bromocriptine administration on tumor size in patients with “nonsecreting” pituitary adenomas
1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
1985
Reenlargement of macroprolactinomas during bromocriptine treatment: report of two cases
1983
Medulloblastoma. Results of a sequential combined treatment
1984